The purpose of this study was to investigate the effects of plasminogen activator inhibitor-1 (PAI-1) gene (SERPINE1) single nucleotide polymorphisms (SNPs) on the risk of myocardial infarction (MI), on PAI-1 levels, and factors related to the metabolic syndrom
Background--Plasminogen activator inhibitor type 1 (PAI-1) plays an essential role in the fibrinolys...
AbstractOBJECTIVESThe study was done to assess whether the common polymorphic allele (4G) of the pla...
Type-1 plasminogen activator inhibitor (PAI-1) 4G/5G polymorphism may influence the PAI-1 expression...
The purpose of this study was to investigate the effects of plasminogen activator inhibitor-1 (PAI-1...
Activation of inflammation and coagulation are closely related andmutually interdependent in myocard...
Background: The circulating levels of plasminogen activator inhibitor type 1 (PAI-1) are increased i...
We conducted a genome-wide association study to identify novel associations between genetic variants...
Plasminogen activator inhibitor-1 (PAI-1), a rapid inhibitor of tissue-type plasminogen activator, h...
BACKGROUND: The 4G allele in the promoter region of the plasminogen activator inhibitor type 1 (PAI-...
Although the potential role of plasminogen activator inhibitor-1 (PAI-1) in the development of coron...
We conducted a genome-wide association study to identify novel associations between genetic variants...
The habitual level of PAI-1 is influenced by many factors, of which obesity and insulin resistance a...
BackgroundMyocardial Infarction (MI) was reportedly precipitated by acquired and inherited risk fact...
Plasminogen activator inhibitor type 1 (PAI-1) plays an essential role in the fibrinolysis system an...
Plasminogen activator inhibitor-type 1 (PAI-1) is the main inhibitor of fibrinolysis and a potential...
Background--Plasminogen activator inhibitor type 1 (PAI-1) plays an essential role in the fibrinolys...
AbstractOBJECTIVESThe study was done to assess whether the common polymorphic allele (4G) of the pla...
Type-1 plasminogen activator inhibitor (PAI-1) 4G/5G polymorphism may influence the PAI-1 expression...
The purpose of this study was to investigate the effects of plasminogen activator inhibitor-1 (PAI-1...
Activation of inflammation and coagulation are closely related andmutually interdependent in myocard...
Background: The circulating levels of plasminogen activator inhibitor type 1 (PAI-1) are increased i...
We conducted a genome-wide association study to identify novel associations between genetic variants...
Plasminogen activator inhibitor-1 (PAI-1), a rapid inhibitor of tissue-type plasminogen activator, h...
BACKGROUND: The 4G allele in the promoter region of the plasminogen activator inhibitor type 1 (PAI-...
Although the potential role of plasminogen activator inhibitor-1 (PAI-1) in the development of coron...
We conducted a genome-wide association study to identify novel associations between genetic variants...
The habitual level of PAI-1 is influenced by many factors, of which obesity and insulin resistance a...
BackgroundMyocardial Infarction (MI) was reportedly precipitated by acquired and inherited risk fact...
Plasminogen activator inhibitor type 1 (PAI-1) plays an essential role in the fibrinolysis system an...
Plasminogen activator inhibitor-type 1 (PAI-1) is the main inhibitor of fibrinolysis and a potential...
Background--Plasminogen activator inhibitor type 1 (PAI-1) plays an essential role in the fibrinolys...
AbstractOBJECTIVESThe study was done to assess whether the common polymorphic allele (4G) of the pla...
Type-1 plasminogen activator inhibitor (PAI-1) 4G/5G polymorphism may influence the PAI-1 expression...